Translational cancer researcher specializing in bladder cancer, with expertise in circulating tumor DNA (ctDNA), liquid biopsy technologies, tumor heterogeneity, mutational dynamics, and next-generation sequencing (NGS) methodologies
My research focuses on bladder cancer genomics, tumor evolution, and ctDNA-based monitoring of minimal residual disease and treatment response. I specialize in exome, whole-genome, and targeted sequencing of cfDNA and tissue, applied in both prospective trials and retrospective cohort studies. My research has contributed to key discoveries in bladder cancer subtypes, ctDNA detection, mutational signatures, and TCR repertoire profiling.
I regularly teach and supervise Master's and PhD students in molecular biology and ctDNA analysis. This includes hands-on instruction in NGS methods, data interpretation, and experimental design. I have taught international PhD courses at Aarhus University and mentored early-career researchers on translational cancer projects.
I collaborate closely with clinical departments, national cancer centers, and international academic institutions across Denmark, Europe, and the USA. Ongoing consortia include a multicenter Phase III trials TOMBOLA) and translational research networks integrating ctDNA, immunotherapy, and genomics. I also contribute to academic–industry partnerships and cross-disciplinary initiatives focused on precision oncology and biomarker development.
